baber/WOPTO huggingface dataset:
Patent MX-PA05006484-A (MX)
Title: Absorbent article with improved leak guards.
Inventor: MARK S FRANKE
IPC: A61F13/15
Filed: 2003-09-18
Abstract: An absorbent article is provided having a chassis with a front waist region, a back waist region, and a crotch region extending longitudinally between the front and back waist regions. An absorbent body structure extends longitudinally generally from the front waist region to the back waist region. Longitudinally extending leak guards are provided having a free laterally inward side and a laterally outward side attached to the chassis laterally outward of the absorbent body structure so as to define respective containment pockets along opposite lateral sides of the absorbent body structure. The leak guards are substantially elastomeric in a transverse direction along their longitudinal length.
Patent MX-PA05008347-A (MX)
Title: Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis.
Inventor: STEPHEN RUBIN
IPC: A61K31/4196
Filed: 2004-02-03
Abstract: The invention relates to a method of treating endometriosis using a combination of an aromatase inhibitor, a progestin and an oestrogen. The invention also relates to pharmaceutical formulations comprising said combination.
Patent MX-PA05009965-A (MX)
Title: Method and apparatus for improving video quality of low bit-rate video.
Inventor: IRVINE ANN C
IPC: H04N7/26
Filed: 2004-03-17
Abstract: Embodiments describe a method, apparatus and system for processing images using block based compression. In one embodiment, a method comprises determining whether two blocks are neighboring blocks, determining whether the two neighboring blocks are both subdivided, if the two blocks are neighboring blocks; performing deblocking filtering on one or more edge pixels of the two neighboring blocks, if it is determined that both of the two neighboring blocks are not subdivided.
Patent MX-PA05010199-A (MX)
Title: Process for recycling detergent pouches.
Inventor: SMITH DAVID JOHN
IPC: C11D17/04
Filed: 2004-03-24
Abstract: Process for treating or recycling a waste single or multi-compartment detergent pouch containing one or more detergent or detergent auxiliary compositions enclosed within a water-soluble enveloping material.
Patent MX-PA05010652-A (MX)
Title: Substituted pyrazoles.
Inventor: KAI SCHIEMANN
IPC: C07D405/04
Filed: 2004-03-08
Abstract: The invention relates to the compounds of formula (I) and the salts and solvates thereof, wherein X, R1, R2, R3, R4 and R5 are defined as in claim 1. The inventive compounds are suitable as ligands of 5 HT receptors.
Patent MX-PA05011504-A (MX)
Title: Multicolor resin molding component for mobile apparatus.
Inventor: YASUHARA TAKASHI
IPC: H01H13/14
Filed: 2004-04-15
Abstract: A multicolor resin molding component for a mobile apparatus in which higher-degree, diversified designs of the key top or the decoration member of a push button are realized by developing a metal plating decorating means. The key top or the decoration member of a target push button is formed by multicolor resin molding for molding different resin materials integrally and a plating film of the same metal or plating films of different metals are applied to a plurality of regions on the surface of the resin component isolated from each other.
Patent MX-PA05013684-A (MX)
Title: Cationic cassia derivatives and applications therefor.
Inventor: HASMAN DANIEL F JR
IPC: C11D3/22
Filed: 2004-06-18
Abstract: This invention relates to cationically derivatized polygalactomannans obtained from cassia tora and cassia obtusifolia and to their use in personal care, household care, and institutional care compositions.
Patent MX-PA05013794-A (MX)
Title: Container made from thermoplastic material with a domed base.
Inventor: BOUKOBZA MICHEL
IPC: B65D1/02
Filed: 2004-06-11
Abstract: The invention relates to a container (1), made from thermoplastic material (3), of the type with a domed base, comprising a central projecting pimple (4), a peripheral support region (5) and an intermediate arch (6), provided with ribs (7), extending from the central pimple to the support region but not therein, the ribs (7) having a dihedral form with a straight section in a V in the medial plane (7c), essentially parallel to the axis (1a) of the container and running into each other without a break. The ribs (7) have a longitudinal profile which is curvilinear, the bases (7d) of the ribs, in the region thereof adjacent to the central pimple (4), extending higher than the base of said central pimple and the bases (7d) and crests (7e) of the ribs, in the region thereof adjacent to the support region, having curves merging progressively into a continuous rounding of unbroken curvature immediately above the support region (5) such that the latter is essentially planar and continuous over the whole length thereof.
Patent MX-PA06000013-A (MX)
Title: Therapeutic agent for soft tissue sarcoma.
Inventor: OUCHIDA MAMORU
IPC: A61P35/00
Filed: 2004-06-25
Abstract: The present invention relates to a therapeutic agent for soft tissue sarcoma (particularly synovial sarcoma), which contains a histone deacetylase inhibitor (particularly compound A) as an active ingredient.
Patent MX-PA06000113-A (MX)
Title: Thin foamed polyethylene sheets.
Inventor: MARTINEZ FELIPE
IPC: C08J9/00
Filed: 2004-06-30
Abstract: The present invention relates to the use of particular blends of LLDPE and LDPE together with specific fabrication conditions to make foamed sheets of thin gauge with MD tear properties similar to an equivalent gauge non-foamed sheet of the same composition. In particular, blends which combine a high MI LLDPE rich fraction with a low MI branched LDPE minor fraction provide the adequate balance of mechanical strength of the polymer base with its melt strength, extensibility and stress relaxation, allowing a thin foam film with MD tear strength which is comparable to non foamed counterparts of similar gauge and composition. The foamed films of the present invention are thin (generally from about I to 10 mils thick), and have an MD tear strength of at least about 160 grams for a 3 mil film as measured by ASTM D 1922. The foamed films of the present invention are preferably made at least in part from blends which comprise from 10 to 95 percent by weight of LLDPE having a relatively high (1.5 to 6) MI and from 5 to 90 percent of an LDPE resin having a relatively low MI (0.5 to 2.0).
Patent MX-PA06002668-A (MX)
Title: NONSEDATING Alpha-2 AGONIST 1- (2, 3-DIMETHYL-PHENYL) -ETHYL-1, 3-DIHYDRO-IMIZADOLE-2-THIONE.
Inventor: HEIDELBAUGH TODD M
IPC: C07D233/84
Filed: 2004-08-20
Abstract: The present invention provides an alpha-2A/alpha-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof. The present invention further provides a pharmaceutical composition that contains a pharmaceutical carrier and a therapeutically effective amount of an alpha-2A/alpha-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof.
Patent MX-PA06005169-A (MX)
Title: Oxidation process and catalyst.
Inventor: RIZKALLA NABIL
IPC: C07D301/10
Filed: 2004-11-09
Abstract: Ethylene is oxidized by contact at oxidizing conditions with an admixture of a solid particulate catalyst and a solid particulate alkali metal i treated inert.
Patent MX-PA06007973-A (MX)
Title: Personal protective device and method of using the same.
Inventor: NADEAU JUSTIN P
IPC: A01M29/16
Filed: 2004-01-12
Abstract: A personal protective device (and method of its use) comprising a marine and land transmission detraction and deterrence device designed to protect swimmers, scuba divers, surfers, hikers, hunters, campers and other individuals engaged in water and/or land activities from attacks by sharks as well as from attacks from other marine and land predators of human beings. The device emits a high frequency pitch in varying sequential intervals that is easily heard and recognized by sharks and/or by other targeted land and marine human predators. The personal protective device comprises sound generator means for reproducing a sound known to repel predators; a piezoelectric speaker; and a power supply for supplying electrical energy to the sound generator means and speaker contained in a waterproof package.
Patent MX-PA06014780-A (MX)
Title: Cartridge and sensor-dispensing instrument.
Inventor: KHEIRI MOHAMMAD A
IPC: G01N33/00
Filed: 2005-06-23
Abstract: A disposable cartridge adapted to be used with a sensor-dispensing instrumentcomprises a housing, test sensors, a mechanical mechanism and moveable seals.The housing forms at least one opening there through. The test sensors are stackedin the housing. The test sensors are adapted to assist in testing at least one analyte.The mechanical mechanism is adapted to urge the test sensors in a first direction.One of the test sensors is positioned for ejection from the cartridge. The moveableseals is adapted to be in a closed position that seals the at least one opening soas to provide a substantially moisture-proof and a substantially air-tightcartridge, and one of the moveable seals is adapted to be in an open position thatallows one of the test sensors to be moved therethrough.
Patent MY-101126-A (MY)
Title: Novel compounds
Inventor: MICHAEL RAYMOND HARNDEN
IPC: C07D473/32
Filed: 1986-12-10
Abstract: COMPOUNDS OF FORMULA (1) AND A PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF: (FORMULA 1) WHEREIN: R1 IS HYDROGEN OR CH2OH; R2 IS HYDROGEN OR, (WHEN R1 AND R2 IS HYDROGEN), HYDROXY OR CH2OH; R? IS CH2OH OR, (WHEN R1 AND R2 ARE BOTH HYDROGEN), CH (OH) CH2 OH; R4 IS HYDROGEN, HYDROXY, AMINO OR OR5 WHEREIN R5 IS C1-6 ALKYL, PHENYL OR PHENYL C1-2 ALKYL EITHER OF WHICH PHENYL MOIETIES MAY BE SUBSTITUTED BY ONE OR TWO HALO, C1-4 ALKYL OR C1-4 ALKOXY GROUPS; AND IN WHICH ANY OH GROUPS IN R1, R2 AND/OR R3 MAY BE IN THE FORM OF O-ACYL, PHOSPHATE, CYCLIC ACETAL OR CYCLIC CARBONATE DERIVATIVES THEREOF; HAVING ANTIVIRAL ACTIVITY, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS.
Patent MY-100313-A (MY)
Title: Dialytic silica dentifrice
Inventor: MILTON EDWARD WINYALL
IPC: C01B33/18
Filed: 1987-02-16
Abstract: A DENTIFRICE COMPOSITION WHICH CONTAINS A PARTICULATE, DIALYTIC SILICA ABRASIVE/THICKENING AGENT HAVING A PORE VOLUME OF 0.1 TO 6 CC/G AND A LARGE PROPORTION OF PORES GREATER THAN 3000 A? (3 X 10-7 M).(FIG.1)
Patent MY-103030-A (MY)
Title: Diacyl derivatives of 4-(triakylbenzyl) -piperazinyl compounds
Inventor: DR KLAUS MULLER
IPC: C07D498/08
Filed: 1987-10-01
Abstract: COMPOUNDS OF THE FORMULA (FORMULA. 1) IN WHICH R REPRESENTS LOWER ALKYL, R1 REPRESENTS TRILOWER ALKYLEMETHYLCARBONYL, AND ONE OF THE RADICALS R2 AND R3 REPRESENTS TRI-LOWER ALKYLMETHYLCARBONYL AND THE OTHER REPRESENTS HYDROGEN, AND SALTS THEREOF, EXHIBIT HYPOLIPIDEMIC PROPERTIES.
Patent MY-106833-A (MY)
Title: Bulk tube handling system.
Inventor: LEE SUN LONG
IPC: B65G47/256
Filed: 1990-10-10
Abstract: THE INVENTION RELATES TO A METHOD OF ARRANGING ELONGATE ARTICLES (28) OF NON-CIRCULAR CROSS SECTION IN A DESIRED ORIENTATION. THE METHOD COMPRISES FEEDING THE ARTICLES (28), IN A DIRECTION TRANSVERSE TO THEIR LONGITUDINAL AXIS, BETWEEN A GUIDE MEMBER (13B) AND A ROTATING ROLLER (13A). THE GAP G BETWEEN THE GUIDE MEMBER (13B) AND THE ROTATING ROLLER IS MADE SUFFICIENTLY WIDE TO PERMIT EACH ARTICLE (28) TO PASS THROUGH THE GAP G ONLY IN PERMITTED ORIENTATIONS ABOUT THE LONGITUDINAL AXIS OF THE ARTICLE (28). THE METHOD FURTHER COMPRISES DETECTING WHICH OF THE PERMITTED ORIENTATIONS IS ADAPTED BY EACH ARTICLE (28) UPON PASSING THROUGH THE GAP G AND, UNLESS THE ORIENTATION OF AN ARTICLE (28) IS A DESIRED ORIENTATION, ROTATING THAT ARTICLE (28) ABOUT ITS LONGITUDINAL AXIS TO THE DESIRED ORIENTATION. A DISC UNIT (33) IS INTERCONNECTED WITH THE DEVICE 4 WHICH ORIENTATES THE ARTICLES (28) AND SERVES TO CONTROL THE ROTATION OF THE DEVICE 4 TO ACHIEVE THE DESIRED ORIENTATION.(FIG. 1)
Patent MY-111771-A (MY)
Title: Transparent, antistatic thermoplastic composition and methods of making the same.
Inventor: GEORGE E NIZNIK
IPC: C08F8/30
Filed: 1994-11-14
Abstract: TRANSPARENT METHACRYLATE-ACRYLONITRILE-BUTADIENE-STYRENE (MABS) THERMOSPLASTIC COPOLYMERS MAY BE PROVIDED WITH ELECTROSTATIC DISSIPATIVE (ESD) PROPERTIES, WHILE MAINTAINING OR ENHANCING PHYSICAL PROPERTIES OF THE MABS, SUCH AS IMPACT STRENGTH, BY BLENDING THE MABS WITH AN INHERENTLY ANTISTATIC THERMOSPLASTIC URETHANE COPOLYMER WHICH IS THE REACTION PRODUCT OF A HYDROXY-TERMINATED POLYALKYLENE ETHER OLIGIMER, A C2-C6 ALKANEDIOL AND AN AROMATIC DIISOCYANATE, AND COMPATIBILIZING THE BLEND OF MABS AND URETHANE WITH AN ACRYLONITRILE-BUTADIENE-STYRENE RUBBERY COPOLYMER PRODUCED BY EMULSION POLYMERIZATION CONTAINING AT LEAST 40 WEIGHT PERCENT BUTADIENE MONOMER AND A RATIO OF STYRENE TO ACRLONITRILE WHICH WILL PRODUCE A RUBBERY COPOLYMER HAVING A REFRACTIVE INDEX IN THE RANGE OF ABOUT 1:53 TO 1:55. ALL THREE COPOLYMER COMPONENTS OF THE TRANSPARENT BLEND HAVE REFRACTIVE INDICES IN THE RANGE OF BAOUT 1:53 TO 1 :55.
Patent MY-114098-A (MY)
Title: Air separation
Inventor: THOMAS RATHBONE
IPC: F25J3/00
Filed: 1995-07-24
Abstract: AIR IS COMPRESSED IN A COMPRESSOR 2, COOLED IN A MAIN HEAT EXCHANGER 6, PARTIALLY CONDENSED IN A REBOILER-CONDENSER 12, INTRODUCED INTO A HIGHER PRESSURE RECTIFIER 14, AND SEPARATED THEREIN INTO NITROGEN AND OXYGEN-ENRICHED LIQUID. RESULTING NITROGEN IS CONDENSED IN FURTHER REBOILER-CONDENSERS 26 AND 28. ONE PART OF THE CONDENSATE IS USED AS REFLUX IN THE HIGHER PRESSURE RECTIFIER 1 4 AND ANOTHER PART AS REFLUX IN A LOWER PRESSURE RECTIFIER 24. A STREAM OF OXYGEN-ENRICHED LIQUID IS WITHDRAWN FROM THE RECTIFIER 14 AND SENT TO AN INTERMEDIATE PRESSURE RECTIFIER 30 WHICH IS REBOILED BY THE REBOILER-CONDENSER 28 AND IN WHICH FURTHER NITROGEN IS SEPARATED. A STREAM OF LIQUID FURTHER ENRICHED IN OXYGEN IS WITHDRAWN FROM THE BOTTOM OF THE INTERMEDIATE PRESSURE RECTIFIER 30 AND IS SEPARATED IN THE LOWER PRESSURE RECTIFIER 24. IMPURE AND PURE OXYGEN PRODUCTS ARE WITHDRAWN RESPECTIVELY FROM OUTLETS 88 AND 84. IN ADDITION AN ARGON- ENRICHED OXYGEN STREAM IS WITHDRAWN FROM THE LOWER PRESSURE RECTIFIER 24 THROUGH AN OUTLET 92 AND SEPARATED IN AN ARGON RECTIFIER 68. FURTHER IMPUREOXYGEN PRODUCT IS WITHDRAWN FROM THE BOTTOM OF THE ARGON RECTIFIER 68 THROUGH AN OUTLET 96. (FIG. 1)
Patent MY-126713-A (MY)
Title: Electrical connector assembly
Inventor: JOSEPH D COMMERCI
IPC: H01R13/28
Filed: 2000-03-17
Abstract: AN ELECTRICAL CONNECTOR ASSEMBLY INCLUDES A PAIR OF HERMAPHRODITIC CONNECTORS (10) HAVING OPPOSED MATING FACES (14) WHICH ARE JUXTAPOSED GENERALLY ALONG A PLANE WHEN THE CONNECTORS ARE MATED. THE CONNECTORS ARE ADDAPTED FOR MATING IN EITHER OPPOSITE DIRECTION (M) GENERALLY PARALLEL TO THE PLANE OF THE MATING FACES (14). EACH CONNECTOR (10) INCLUDES AND ELONGATED HOUSING (12) HAVING AN ENGAGING FLANGE (18) AT ONE END AND A LOCKING HOOK (16) AT AN OPPOSITE END FOR EMBRACING THE ENGAGING FLANGE OF THE OTHER HERMAPHRODITIC CONNECTOR TO LOCK THE CONNECTORS AGAINST UNMATING IN A DIRECTION GENERALLY PERPENDICULAR TO THE PLANE OF THE MATING FACES (14). THE ENGAGING FLANGE (18) AND THE LOCKING HOOK (16) OF THE PAIR OF HERMAPHRODITIC CONNECTORS (10) HAVE OPPOSING ABUTMENT SURFACES (32, 34, 40, 46) THAT ARE ELONGATED IN THE MATING DIRECTION (M) OF THE CONNECTORS. AT LEAST ONE OF THE OPPOSING ABUTMENT SURFACES HAS A CENTRAL ABUTMENT PORTION (36, 42) GENERALLY PARALLEL TO THE MATING DIRECTION (M) AND INCLINED RAMP PORTIONS (38, 44) AT OPPOSITE ENDS OF THE CENTRAL ABUTMENT PORTION IN THE MATING DIRECTION. THIS CONFIGURATION OF THE OPPOSING ABUTMENT SURFACES (32, 34, 40, 46) MINIMIZES BINDING OF THE HOUSINGS (12) IF ATTEMPTS ARE MADE TO MATE THE CONNECTORS (10) IN RELATIVELY SKEWED ORIENTATIONS.FIG.1
Patent MY-119953-A (MY)
Title: Novel method of treatment
Inventor: STORM KEVIN
IPC: A61K47/38
Filed: 2000-04-11
Abstract: THE ADMINISTRATION OF BETWEEN 1900-2600 MG OF AMOXYCILLIN COMBINED WITH AN AMOUNT OF POTASSIUM CLAVULANATE SUCH THAT THE WEIGHT RATIO OF AMOXYCILLIN TO POTASSIUM CLAVULANATE IS FROM 2:1 TO 20:1 IN A TWICE DAILY (BID) DOSAGE REGIME PROVIDES AN EFFECTIVE TREATMENT FOR HUMAN BACTERIAL INFECTIONS SUCH AS THOSE CAUSED BY S. PNEUMONIAE, INCLUDING DRUG RESISTANT S. PNEUMONIAE AND PENICILLIN RESISTANT S. PNEUMONIAE; H.INFLUENZAE AND M CATARRHALIS. THE PREFERRED WEIGHT RATIO OF AMOXYCILLIN TO POTASSIUM CLAVULANATE IS FROM 14:1 TO 20:1 AND PREFERRED DOSAGES ARE 2000/125, 2250/125 OR 2500/125 MG OFAMOXYCILLIN AND POTASSIUM CLAVULANATE RESPECTIVELY. THE ADMINISTRATION OF SUCH DOSAGES PROVIDES A MEAN PLASMA CONCENTRATION OF AMOXYCILLIN OF 4UG/ML FOR AT LEAST 4.4 HRS AND A MEAN MAXIMUM PLASMA CONCENTRATION (CMAX) OF AMOXYCILLIN OF 12 UG/ML. THE DOSE MAY BE ADMINISTERED AS AN IMMEDIATE RELEASE FORMULATION OR AS A MODIFIED RELEASE FORMULATION IN THE FORM OF A ONE OR MORE SACHETS OR ONE OR MORE TABLETS (MONOLITH, DISPERSIBLE, EFFERVESCENT OR CHEWABLE TYPE) OR ONE OR MORE CAPSULES. THE AMOXYCILLIN MAY BE IN THE FORM OF AMOXYCILLIN TRIHYDRATE OR CRYSTALLISED SODIUM AMOXYCILLIN. A NUMBER OF OTHER DOSAGE REGIMES OF AMOXYCILLIN AND POTASSIUM CLAVULANATE ARE ALSO DISCLOSED, I.E. (A) 1400-1900 MG AMOXYCILLIN AND AN AMOUNT OF POTASSIUM CLAVULANATE SUCH THAT THE WEIGHT RATIO OF AMOXYCILLIN TO POTASSIUM CLAVULANATE IS FROM 2:1 TO 14:1 WHICH IS ADMINISTERED TWICE DAILY; AND (B) 950-1300 MG AND AN AMOUNT OF POTASSIUM CLAVULANATE SUCH THAT THE WEIGHT RATIO OF AMOXYCILLIN TO POTASSIUM CLAVULANATE IS FROM 14:1 TO 20:1. THESE DOSAGE FORMS MAY ALSO BE FORMULATED AS AN IMMEDIATE RELEASE FORMULATIONS IN TABLET FORM OR AS SACHET OF POWDER REQUIRING SUBSEQUENT ADDITION OF A LIQUID CARRIER PRIOR TO ADMINISTRATION TO THE PATIENT. THE ANY OF THE DOSAGES DISCLOSED MAY BE FORMULATED AS A MODIFIED RELEASE FORMULATION, SUCH AS A LAYERED TABLET, PREFERABLY A BILAYERED TABLET (SEE FIG 1A), WHERE ALL THE POTASSIUM CLAVULANATE AND A FIRST PORTION OF THE AMOXYCILLIN IS PRESENT IN THE FIRST OR IMMEDIATE RELEASE LAYER (1) AND THE SECOND PORTION OF THE AMOXYCILLIN IS PRESENT IN THE SECOND OR SLOW RELEASE LAYER (2). THE BILAYERED TABLET MAY ALSO CONTAIN COATING LAYERS (4,4A) OR A BARRIER LAYER (3) TO ALLOW FURTHER MODIFICATION OF THE RELEASE CHARACTERISTICS OF THE TABLET (SEE FIGS 1B-1E). A NUMBER OF EXCIPIENTS WITH RELEASE RETARDING PROPERTIES MAY BE ADDED TO THE SLOW RELEASE LAYER, FOR EXAMPLE, XANTHAN GUM; CELLULOSE DERIVATIVES; POLYMER MATERIALS SUCH AS POLYVINYLALCOHOL OR POLYETHYLENE GLYCOLS; AND/OR ORGANIC ACIDS, SUCH AS CITRIC ACID. ALTERNATIVELY, THE DOSAGES MAY BE AVAILABLE AS IN A KIT FORM COMPRISING AN IMMEDIATE RELEASE FORMULATION COMPRISING AMOXYCILLIN AND POTASSIUM CLAVULANATE AND A SLOW RELEASE FORMULATION COMPRISING AMOXYCILLIN ONLY.
Patent MY-123541-A (MY)
Title: Method for defect marking and analysis of thin film hard disks
Inventor: MICHAEL CRAIG COSCI
IPC: G11B5/82
Filed: 2000-10-18
Abstract: THE PRESENT INVENTION IS A METHOD FOR DEFECT LOCATING MARKING AND ANALYSIS OF THIN FILM HARD DISKS.INITIALLY, THE HARD DISK (14) IS DISPOSED IN A DISK DRIVE (10) AND THE DISK (14) IS FORMATTED WITH SECTOR IDENTIFICATION LINES (24) AND DATA WRITTEN INTO DATA TRACKS (28).DURING THE DATA WRITING PROCESS A DISK SURFACE DEFECT (36) IS IDENTIFIED BY ITS SECTOR, TRACK AND BYTE LOCATION. THE HARD DISK (14) IS THEN MARKED SUCH THAT THE DEFECT (36) CAN BE LOCATED AT A LATER TIME.THE ERASED BANDS (70) AID IN LATER LOCATING THE DEFECT (36). AFTER THE DEFECT (36) LOCATING ERASURES HAVE BEEN COMPLATED FOR EACH DEFECT (36) FOUND ON THE DISK (14), THE DISK (14) IS REMOVED FROM THE HARD DISK DRIVE (10) FOR FURTHER ANALYSIS.THE DISK (14) IS THEN PLACED ON THE STAGE OF A MICROSCOPE AND FERROMAGNETIC FLUID IS APPLIED TO THE DISK (14) IN ORDER TO MAKE THE ERASED TRACKS (50, 54) VISIBLE. THE FERROMAGNETIC FLUID IS APPLIED OUT TO THE END OF THE TRACK ERASURE OF THE TRACK THAN INCLUDES THE DEFECT (36), WITHOUT APPLICATION OF FERROMAGNETIC FLUID TO THE DEFECT (36) ITSELF.AS A RESULT, THE SPECIFIC DEFECT IS VISUALLY LOCATED FOR FURTHER ANALYSIS IN ITS ORIGINAL CONDITION, WITHOUT DISK ERASURE OVER IT, AND WITHOUT THE APPLICATION OF APPLICATION OF FERROMAGNETIC FLUID UPON IT. BECAUSE THE DEFECT (36) IS IN ITS ORIGINAL CONDITION A MORE PRECISE AND ACCURATE ANALYSIS OF THE NATURE OF THE DEFECT (36) CAN BE MADE. (FIG .2)
Patent MY-135962-A (MY)
Title: Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
Inventor: MARTIN PAULINE L
IPC: C07H19/16
Filed: 2000-11-16
Abstract: THE PRESENT INVENTION DISCLOSES A METHOD FOR TREATING HEART RHYTHM DISTURBANCES IN A MAMMAL IN NEED THEREOF BY THE ADMINISTRATION OF N6-SUBSTITUTED- 5''(N-SUBSTITUTED)CARBOXAMIDOADENOSINES. MORE PARTICULARLY, THE INVENTION IS DIRECTED TO A METHOD FOR TREATMENT OF HEART RHYTHM DISTURBANCES IN A MAMMAL THAT WOULD BENEFIT FROM THE INDUCTION OF NEGATIVE DROMOTROPIC AND/OR NEGATIVE CHRONOTROPIC ACTIONS, COMPRISING THE ADMINISTRATION TO SAID MAMMAM AN EFFECTIVE AMOUNT OF A COMPOUND OF THE FORMULA :(FORMULA)OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF; WHEREIN R1 IS C3-7 SECONDARY ALKYL, OR C3-8 CYCLOALKYL; ANDR2 IS C1-4 ALKYL OR C3-5 CYCLOALKYLTHE INVENTION IS ALSO DIRECTED TO NOVEL DOSAGE FORMS COMPRISING SAID COMPOUNDS.
Patent MY-134557-A (MY)
Title: Method for multiple suppression based on phase arrays
Inventor: LEE PAUL J
IPC: H04R1/02
Filed: 2001-12-07
Abstract: AN APPARATUS AND METHOD FOR SUPPRESSING MULTIPLES IN THE COLLECTION OF MARINE SEISMIC DATA COMPRISES AT LEAST ONE SOURCE POSITIONED IN THE BODY OF WATER (102); AT LEAST ONE RECEIVER (105) POSITIONED IN THE BODY OF WATER (102) BELOW THE AIR-WATER INTERFACE (103) AND NEAR THE SOURCES; A BUBBLE DIFFUSER (101) POSITIONED IN THE BODY OF WATER (102) SO THAT THE BUBBLES (108) EMITTED BY THE BUBBLE DIFFUSER (101) ARE POSITIONED BETWEEN THE RECEIVERS (105) AND THE AIR-WATER INTERFACE (103), WHEREIN THE EMITTED BUBBLES (108) PROVIDE HIGH ACOUSTIC REFLECTION AND SUBSTANTIALLY SUPPRESS SPECULAR REFLECTION OF SEISMIC WAVES; AND A CONTROL FOR ACTIVATING THE BUBBLE DIFFUSER (101) DURING THE COLLECTION OF SEISMIC DATA BY THE SOURCES AND RECEIVERS (105).(FIG 4)
Patent MY-126193-A (MY)
Title: Preparing epoxy resin by distilling two fractions to recover and reuse epihalohydrin without glycidol
Inventor: OGURA ICHIRO
IPC: C08G59/06
Filed: 2002-09-27
Abstract: ENERGY COST IS REDUCED AND REUSE EFFICIENCY OF EPIHALOHYDRIN AND INDUSTRIAL PRODUCTIVITY IN THE PROCESS FOR PREPARING AN EPOXY RESIN, WHICH USES A RECOVERED EPIHALOHYDRIN HAVIG A LOW GLYCIDOL CONTENT, ARE REMARKABLY IMPROVED. IN THE PROCESS FOR PREPARING AN EPOXY RESIN BY REACTING A POLYHYDRIC PHENOL COMPOUND WITH EPIHALOHYDRIN IN A WATER-SOLUBLE ORGANIC SOLVENT IN THE PRESENCE OF AN ALKALI REACTIVE CATALYST, FIRST , A FIRST RECOVERED FRACTION CONTAINING A SMALL AMOUNT OF THE BY-PRODUCT GLYCIDOL IS RECOVERED WHILE CONTINUOUSLY DISTILLING A DISTILLED COMPONENT FROM THE CRUDE REACTION PRODUCT AFTER THE COMPLETION OF THE REACTION, AND THEN A SECOND RECOVERED FRACTION CONTAINING A SMALL AMOUNT OF THE WATER-SOLUBLE ORGANIC SOLVENT IS RECOVERED FRACTION IS WASHED WITH WATER TO OBTAIN A PURIFIED FRACTION AND THE PURIFIED FRACTION IS USED AS A RAW MATERIAL FOR SUNTHESIS OF THE EPOXY RESIN, TOGETHER WITH THE FIRST RECOVERED FRACTION.